In this study, we assessed changes in TIL count and PD-L1 expression in paired pre-neoadjuvant and post-neoadjuvant chemotherapy tissues and correlated residual cancer TIL counts and PD-L1 expression and change in these parameters with survival. The gene discussed is CD274; the disease is cancer.